Use of L'Abbe and pooled calibration plots to assess the relationship between severity of illness and effectiveness in studies of corticosteroids for severe sepsis

被引:18
作者
Ho, K. M. [1 ,2 ]
Tan, J. A. [1 ]
机构
[1] Royal Perth Hosp, Dept Intens Care Med, Perth, WA 6000, Australia
[2] Univ Western Australia, Sch Populat Hlth, Perth, WA 6000, Australia
关键词
clinical trials; predicted mortality; quality of study; standardized mortality ratio; COMMUNITY-ACQUIRED PNEUMONIA; HYPERDYNAMIC SEPTIC SHOCK; CRITICALLY-ILL PATIENTS; LOW-DOSE HYDROCORTISONE; THERAPY; EFFICACY; TRIALS; PERSPECTIVE; ADULTS; DEATH;
D O I
10.1093/bja/aeq417
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background. The role of corticosteroids in severe sepsis and pneumonia remains controversial. This study described the use of L'Abbe and pooled calibration plots to assess the relationship between severity of illness and effectiveness of corticosteroids for severe sepsis. Methods. Randomized controlled trials (RCTs) comparing corticosteroids and placebo from Cochrane Controlled Trial Register, MEDLINE, and EMBASE databases were retrieved. The observed and predicted mortality rates of the placebo groups were used as a measure of the severity of illness of the patients in L'Abbe and calibration plots. Results. A total of 1089 patients from 10 RCTs fulfilled the inclusion criteria and were subject to further analysis. L'Abbe and calibration plots did not suggest significant interactions between the effectiveness of corticosteroids and severity of illness. The pooled calibration plot suggested that the mortality rates of the placebo groups from three studies were higher than predicted. After excluding these studies in the meta-analysis, there was a reduction in the point estimate of benefit of corticosteroids on mortality [odds ratio (OR) 0.97, 95% confidence interval (CI): 0.71-1.33, P = 0.87 by a fixed-effect model, P = 0.59 by a random-effects model vs OR 0.85, 95% CI: 0.66-1.10%]. Conclusions. The pooled calibration plot suggested that there were excessive deaths in the placebo groups of some RCTs that could explain the apparent benefit of corticosteroids on mortality of patients with severe sepsis. L'Abbe and pooled calibration plots might be useful as adjuncts to assess interactions between severity of illness and effectiveness of an intervention.
引用
收藏
页码:528 / 536
页数:9
相关论文
共 27 条
[1]   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[2]   Multicentre trials: a US regulatory perspective [J].
Anello, C ;
O'Neill, RT ;
Dubey, S .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2005, 14 (03) :303-318
[3]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[4]   Corticosteroids for community-acquired pneumonia: time to act! [J].
Annane, Djillali ;
Meduri, G. Umberto .
CRITICAL CARE, 2008, 12 (04)
[5]   Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults A Systematic Review [J].
Annane, Djillali ;
Bellissant, Eric ;
Bollaert, Pierre-Edouard ;
Briegel, Josef ;
Confalonieri, Marco ;
De Gaudio, Raffaele ;
Keh, Didier ;
Kupfer, Yizhak ;
Oppert, Michael ;
Meduri, G. Umberto .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (22) :2362-2375
[6]  
[Anonymous], 2001, SYSTEMATIC REV HLTH, DOI DOI 10.1002/9780470693926
[7]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[8]   Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study [J].
Briegel, J ;
Forst, H ;
Haller, M ;
Schelling, G ;
Kilger, E ;
Kuprat, G ;
Hemmer, B ;
Hummel, T ;
Lenhart, A ;
Heyduck, M ;
Stoll, C ;
Peter, K .
CRITICAL CARE MEDICINE, 1999, 27 (04) :723-732
[9]   Early dexamethasone treatment for septic shock patients:: a prospective randomized clinical trial [J].
Cicarelli, Domingos Dias ;
Vieira, Joaquim Edson ;
Martins Bensenor, Fabio Ely .
SAO PAULO MEDICAL JOURNAL, 2007, 125 (04) :237-241
[10]   Hydrocortisone infusion for severe community-acquired pneumonia - A preliminary randomized study [J].
Confalonieri, M ;
Urbino, R ;
Potena, A ;
Piattella, M ;
Parigi, P ;
Puccio, G ;
Della Porta, R ;
Giorgio, C ;
Blasi, F ;
Umberger, R ;
Meduri, GU .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (03) :242-248